search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Toegevoegde Waarde van Dual Source CT voor het Karakteriseren van hart en long Afwijkingen.


- candidate number5978
- NTR NumberNTR1870
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-jun-2009
- Secondary IDsNL28355.068.09 
- Public TitleToegevoegde Waarde van Dual Source CT voor het Karakteriseren van hart en long Afwijkingen.
- Scientific TitleAdded Diagnostic Value of Interleaved Spiral Multidector Row Dual Source CT for Characterization of Cardiopulmonary Abnormalities.
- ACRONYMAdded Diagnostic value of DSCT
- hypothesis1. DSCT-CA will detect additional relevant intrapulmonary abnormalities when the entire chest is included in the examination of the coronary arteries;
2. DSCT-CA of the coronary arteries in patients undergoing DSCT of the chest for non-coronary indications will yield additional clinically relevant diagnostic information;
3. Current follow-up frequency according to the Fleischner Society recommendations can be safely reduced in patients undergoing DSCT-CA of the coronary arteries in whom small pulmonary nodules (<8 mm) are found.
- Healt Condition(s) or Problem(s) studiedCardiovascular disease, Lung
- Inclusion criteria1. CT of the heart or CT of the thorax for clinical indication;
2. Dataset evaluable.
- Exclusion criteria1. Dataset not evaluable.
- mec approval receivedno
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-sep-2009
- planned closingdate1-sep-2012
- Target number of participants0
- InterventionsNone.
- Primary outcome1. Number and type of extra-cardiac findings in CCT;
2. Percentage of tumour growth/ development in incidentally found pulmonary nodules at follow-up CT and/or biopsy;
3. Imaging characteristics of (pre-)malignant nodules;
4. Number of cardiac findings in TCT (presence or absence of coronary stenosis and grade as well as other cardiac findings).
- Secondary outcome1. Percentage of exams performed according to the Fleischner criteria after discovery of a pulmonary nodule that are unchanged at follow-up.
- TimepointsMedical records will be observed 2 years after first examination.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES
- CONTACT for SCIENTIFIC QUERIES
- Sponsor/Initiator Maastricht University Medical Center (MUMC+)
- Funding
(Source(s) of Monetary or Material Support)
- PublicationsN/A
- Brief summaryN/A
- Main changes (audit trail)
- RECORD18-jun-2009 - 19-sep-2014


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl